Efficacy of Dupilumab in the Prevention of Seasonal Exacerbations in Patients With and Without Evidence of an Allergic Asthma Phenotype

被引:0
|
作者
Peters, Anju [1 ]
Sagara, Hironori [2 ]
Corren, Jonathan [3 ]
Domingo, Christian [4 ]
Daizadeh, Nadia [5 ]
Ortiz, Benjamin [6 ]
Djandji, Michel [5 ]
Rowe, Paul [7 ]
Jacob-Nara, Juby [7 ]
Crikelair, Nora [6 ]
Deniz, Yamo [6 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Showa Univ, Sch Med, Dept Med, Div Resp Med & Allergol, Tokyo, Japan
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Autonomous Univ Barcelona, Corporacio Sanitaria Parc Tauli, Pulm Serv, Barcelona, Spain
[5] Sanofi, Cambridge, MA USA
[6] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[7] Sanofi, Bridgewater, NJ USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
190
引用
收藏
页码:AB63 / AB63
页数:1
相关论文
共 50 条
  • [31] Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma
    Brusselle, Guy
    Quirce, Santiago
    Papi, Alberto
    Kuna, Piotr
    Chipps, Bradley E.
    Hanania, Nicola A.
    Blaiss, Michael
    Msihid, Jerome
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Gall, Rebecca
    Ortiz, Benjamin
    Djandji, Michel
    Radwan, Amr
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (03): : 873 - 884.e11
  • [32] Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma
    Weinstein, Steven F.
    Katial, Rohit
    Jayawardena, Shyamalie
    Pirozzi, Gianluca
    Staudinger, Heribert
    Eckert, Laurent
    Joish, Vijay N.
    Amin, Nikhil
    Maroni, Jaman
    Rowe, Paul
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (01) : 171 - +
  • [33] Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis
    Weinstein, Steven
    Staudinger, Heribert
    Guillonneau, Sophie
    Taniou, Christine
    Eckert, Laurent
    Joish, Vijay
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Graham, Neil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [34] Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils
    Bleecker, Eugene R.
    Panettieri, Reynold A.
    Lugogo, Njira L.
    Corren, Jonathan
    Daizadeh, Nadia
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Khodzhayev, Angela
    Soler, Xavier
    Ferro, Thomas J.
    Hansen, Christopher N.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2023, 2023
  • [35] Long-Term Dupilumab Efficacy on Severe Exacerbations and Lung Function in Patients with Type 2 Asthma
    Papi, Alberto
    Castro, Mario
    Busse, William W.
    Langton, David
    Korn, Stephanie
    Xia, Changming
    Pandit-Abid, Nami
    Radwan, Amr
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (04) : 675 - 679
  • [36] LONG-TERM DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN TYPE 2 PATIENTS WITH/WITHOUT ALLERGIC
    Sher, L.
    Corren, J.
    Pavord, I.
    Pandit-Abid, N.
    Radwan, A.
    Jacob-Nara, J.
    Deniz, Y.
    Rowe, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S44 - S45
  • [37] Seasonal (monthly) variation in asthma exacerbations, in patients with asthma, in Greece
    Vourdas, D.
    Petalas, K.
    Grigoreas, C.
    ALLERGY, 2009, 64 : 328 - 328
  • [38] Efficacy of omalizumab therapy in asthma patients with or without asthma-related and allergic comorbidities
    Chen, M.
    Choo, E.
    Yoo, B.
    Raut, P.
    Haselkorn, T.
    Pazwash, H.
    Holweg, C. T. J.
    Hudes, G.
    ALLERGY, 2019, 74 : 36 - 36
  • [39] EFFICACY OF DUPILUMAB IN PATIENTS WITH ASTHMA WITH/WITHOUT SUBSTANTIAL REDUCTION IN FRACTIONAL EXHALED NITRIC OXIDE
    Halpin, D.
    Korn, S.
    Matucci, A.
    Bourdin, A.
    Daizadeh, N.
    Ortiz, B.
    Djandji, M.
    Deniz, Y.
    Rowe, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S34 - S34
  • [40] Dupilumab improves lung function and reduces severe exacerbations in patients with uncontrolled persistent asthma with and without history of atopy
    Maspero, J.
    Gawchik, S. M.
    Zhang, B.
    Pirozzi, G.
    Staudinger, H.
    Evans, R. R.
    Graham, N. M. H.
    Louis-Tisserand, M.
    Teper, A.
    ALLERGY, 2016, 71 : 530 - 530